Gilead Sciences has announced a strategic partnership with Genesis Therapeutics, aimed at using AI to discover and develop ...

Genesis Therapeutics’ shiny AI drug discovery platform GEMS is catching on, having now caught the eye of Gilead Sciences. | ...

Gilead Sciences has been looking for a win for Trodelvy after two ... He also pointed to Gilead’s partnership with Arcus ...

In a study of more than 3,000 participants, Gilead's twice-yearly lenacapavir delivered a 96% reduction in HIV infections compared with background HIV incidence.

Gilead Sciences presented initial data from the ... to accelerate the discovery of new small molecule therapies. The partnership will leverage Genesis' AI platform, GEMS, and is expected to ...

The ball, supported by presenting sponsor Gilead Sciences, will take place at the Beverly Hills Hotel on Sept. 26. In ...

DeepWell Digital Therapeutics received 510 (k) clearance from the FDA on its biofeedback software development kit for use in ...

Avenzo Therapeutics announced a trial partnership and supply agreement with Gilead Sciences to assess a combination regimen ...

ALAN ROSSI SILVA argues that Gilead’s HIV prevention drug, while promising, highlights systemic failures in the ...

More needs to be done to stop stigma toward those living with HIV, including producing more stories featuring those living with HIV, a new report from GLAAD said. Out of all major television shows, ...